ORIC Pharmaceuticals Inc [ORIC] stock prices are saw in change for the day to $9.15 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The ORIC shares have gain 12.27% over the last week, with a monthly amount drifted -8.50%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
ORIC Pharmaceuticals Inc [NASDAQ: ORIC] stock has seen the most recent analyst activity on January 07, 2026, when Piper Sandler initiated its Overweight rating and assigned the stock a price target of $22. Previously, Evercore ISI started tracking the stock with Outperform rating on November 20, 2025, and set its price target to $25. On November 18, 2025, Wolfe Research initiated with a Peer Perform rating. Ladenburg Thalmann initiated its recommendation with a Buy and recommended $15 as its price target on July 08, 2025. Wells Fargo started tracking with an Overweight rating for this stock on October 31, 2024, and assigned it a price target of $20. In a note dated September 06, 2024, Stifel initiated a Buy rating and provided a target price of $20 on this stock.
The stock price of ORIC Pharmaceuticals Inc [ORIC] has been fluctuating between $3.90 and $14.93 over the past year. Currently, Wall Street analysts expect the stock to reach $22 within the next 12 months. ORIC Pharmaceuticals Inc [NASDAQ: ORIC] shares were valued at $9.15 at the most recent close of the market. An investor can expect a potential return of 140.44% based on the average ORIC price forecast.
Analyzing the ORIC fundamentals
Gross Profit Margin for this corporation currently stands at -0.07% with Operating Profit Margin at -138.86%, Pretax Profit Margin comes in at -126.89%, and Net Profit Margin reading is -126.89%. To continue investigating profitability, this company’s Return on Assets is posted at -0.31, Equity is -0.45 and Total Capital is -0.36.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It’s worth pointing out that ORIC Pharmaceuticals Inc [NASDAQ:ORIC]’s Current Ratio is 14.65. Also, the Quick Ratio is 14.65, while the Cash Ratio stands at 2.46.
Transactions by insiders
Recent insider trading involved Multani Pratik S, Chief Medical Officer, that happened on Dec 16 ’25 when 10720.0 shares were sold. Chief Financial Officer, Piscitelli Dominic completed a deal on Dec 16 ’25 to sell 10720.0 shares. Meanwhile, PRESIDENT AND CEO Chacko Jacob sold 33374.0 shares on Dec 16 ’25.
